q3

By Jonah Comstock 02:42 pm November 15, 2018
On its third quarter earnings call last week, Dexcom recapped a busy Q3 — of note, one that included the acquisition of TypeZero Technologies for $11.3 million in August as well as two new FDA clearances in October and November. One of these clearances was for a new mobile app interface for the Dexcom G6 while the other was the Dexcom Pro Q CGM, a new disposable glucose monitoring device intended...
By Jonah Comstock 05:44 am November 7, 2018
By and large, Q3 2018 was a slow and steady quarter for pharma moves in digital health, at least in terms of publicly disclosed operations. At events during the quarter, the likes of Johnson & Johnson, AstraZeneca, Novartis and Sanofi discussed digital therapeutics and expressed a healthy mixture of skepticism and enthusiasm for the space. “These technologies have a tremendous opportunity to...
By Dave Muoio 03:47 pm November 5, 2018
Digital health-focused news involving payers during the third quarter of 2018 comprised a number of different focus areas, ranging from chronic condition management strategies to member engagement to high-profile deals. Read below for MobiHealthNews’ coverage of this sector through July, August and September. Diabetes management and prevention A handful of payer news during this period...
By Brian Dolan 03:23 am October 10, 2013
In every newsletter edition of MobiHealthNews we include a "Quote of the Week" -- we actually do this twice a week since the MobiHealthNews letter goes out on Tuesday and Thursday mornings. That means in order for it to become the new quote of the week, our Thursday quote needs to be even better than our Tuesday one. We also include some of these favorite quotes in our quarterly reports. This...